Training session on the new pharmaceutical legislation

Date

Thursday, 29 November 2012, All day

Location

European Medicines Agency, Amsterdam, the Netherlands

This training session for patient- and consumer-organisation representatives is focusing on the new pharmacovigilance legislation; the Pharmacovigilance Risk Assessment Committee (PRAC); risk-management plans and post-authorisation safety studies; adverse-drug-reaction reporting and signal detection; periodic safety update reports; safety referrals; and the impact of the pharmacovigilance legislation.

Documents

Share this page